Silver-Copper-Cadmium-Zinc Brazing Alloys Lucas-Milhaupt, Inc. Handy & Harman Fairfield 5656 S. Pennsylvania Ave. 1770 Kings Highway Supplier Emergency Contacts & Phone Number ------------------------------------------ Handy & Harman Fairfield: (203) 259-8321 Lucas-Milhaupt, Inc. Handy & Harman Fairfield 5656 S. Pennsylvania Ave. 1770 Kings Highway Manufacturer Emergency Contacts & Phone Number ---------------------------------------------- Handy & Harman Fairfield: (203) 259-8321 Product Name: Silver-Copper-Cadmium-Zinc Brazing Alloys The information in this MSDS is applicable to the products with the following codes: 21-846, Easy-Flo (31-500), Easy-Flo 25 (31-250), Easy-Flo 25HC (31-257), Easy-Flo 30 (31-300), Easy-Flo 35 (31-350), Easy-Flo 40 (31-400) (formerly Alloy 32-405), Easy-Flo 45 (31-450), Braze 200 (32-200), and Trimet 177 (38-177). WARNING: These products contain a chemical(s) known to the State of California tocause cancer and birth defects or other reproductive harm. 2. Composition/Information On Ingredients ----------------------------------------- Eye contact with these products in finely-divided forms may cause irritation, conjunctivitis, ulceration of the cornea, and/or argyria, a permanent blue-gray discoloration of the eyes, skin, mucous membranes, and respiratory tract. Skin contact with these products, particularly in finely-divided forms, may cause irritation, argyria, discoloration, and/or contact dermatitis. Ingestion of these products in finely-divided forms may cause nausea, vomiting,and gastrointestinal irritation. Long-term chronic ingestion may damage the liver, kidneys, gastrointestinal system, and nervous system. Inhalation of the components of these products is not known to present a significant risk to health when used according to instructions and with appropriate protective measures (see Section #8). Inhalation of component elements has been reported to cause one or more of the following symptoms and effects upon excessively high or prolonged exposure: CADMIUM: Acute exposure to cadmium may cause pneumonitis, bronchitis, and pulmonary edema. Chronic exposure may cause gastrointestinal symptoms, anemia, rhinitis, discoloration of teeth, kidney disease, microfractures, and cancer. COPPER: Acute exposure may cause respiratory tractirritation, fever, muscle ache, chills, cough, weakness, and a metallic taste.Chronic exposure may damage the liver, kidney, spleen, pancreas, and brain. SILVER: Chronic exposure via inhalation may cause argyria. ZINC: Acute exposure to zinc oxide may cause respiratory tract irritation and "metal fume fever", which is characterized by a metallic taste, cough, dry throat, chills, fever, tightness of chest, headache, nausea, shortness of Flush affected areas with water for at least fifteen minutes. Seek medical Remove contaminated clothing. Wash affected area with large quantities of water for at least five minutes. Seek medical attention if necessary. Launder or If subject is conscious, induce vomiting. If unconscious or convulsive, seek If signs and symptoms of toxicity are observed, remove subject from area, administer oxygen, and seek medical attention. Keep the subject warm and at rest. Perform artificial respiration if breathing has stopped. None of the components are acutely toxic by ingestion, nor are they absorbed through the skin. Extensive or prolonged skin contact may cause dermatitis and/orargyria. Inhalation of cadmium fume may cause severe respiratory illness. In finely-divided form, these products may ignite when exposed to flame or by reaction with incompatible materials (see Section #10). If present in a fire or explosion, they may emit fumes of the constituent metals or metal oxides. If fighting a fire in which these products are present, wear a self-contained breathing apparatus with full facepiece operated in pressure-demand or other If a finely-divided form of product is spilled, clean up spillage so as to minimize dispersion of dust. Wet sweeping or vacuuming using HEPA filtration No special handling precautions are required. Do not store in proximity to incompatible materials (see Section #10). To minimize ingestion, wash hands and face before eating, drinking, applying 8. Exposure Controls/Personal Protection ---------------------------------------- Use appropriate ventilation (e.g., dilution, local exhaust) adequate to maintain concentrations of all components to within their respective OSHA PELs or Wear eye protection adequate to prevent eye contact with finely-divided forms of product and eye injury from the hazards of brazing. Plastic-frame spectacles with side shields and filter lenses (shade #3 or #4) are recommended. Wear appropriate protective gloves and clothing to prevent skin injuries from the hazards of brazing and/or for prolonged or repeated contact with finely- divided forms of product. Avoid flammable fabrics. If an exposure level exceeds an applicable exposure standard, use a NIOSH- approved respirator having a configuration (type of facepiece, filter media, assigned protection factor, etc.) appropriate to the concentration of the contaminant(s) generated. For guidance on selection and use of respiratory protection, consult American National Standard Z88.2 (ANSI, New York, NY 10036 ACGIH TLVs: 0.01 mg/m3 TWA; 0.002 mg/m3 TWA (respirable fraction) OSHA PELs: 0.1 mg/m3 TWA (fume); 1 mg/m3 (dusts and mists) ACGIH TLVs: 0.2 mg/m3 TWA (fume); 1 mg/m3 TWA (dusts and mists) OSHA PEL: 0.01 mg/m3 TWA ACGIH TLV: 0.1 mg/m3 TWA (metal) ACGIH TLVs: 5 mg/m3 TWA; 10 mg/m3 STEL (as ZnO fume) Odorless silver-white metals in the form of wire, rod, sheet, powder, tape, grain, clad alloys, or preformed shapes. Melting Point: 1110-1170 °F 600-630 °C Hazardous Polymerization: will not occur Silver and copper can form unstable acetylides if in contact with acetylene gas. Ammonia; azides; nitric acid; ethylene imine; chlorine trifluoride; sulfuric acid; inorganic and organic peroxides; peroxyformic acid; oxalic acid; tartaric acid; 1-bromo-2-propyne; permonosulfuric acid; ammonium nitrate; hydrazoic acid; chlorates, barium dioxide; carbon disulfide; halogens; hydroxylamine; hydrazine mononitrate; manganese chloride; performic acid; tellurium. Heating to elevated temperatures may liberate metal/metal oxide fumes. Cadmium is classified as a potential human carcinogen by IARC (Group 1) and NTP(Group R). It is also regulated as a carcinogen by OSHA. No other components of this product are classified as potential or demonstrated human In experimental studies, cadmium has been found to cause reproductive abnormalities, including reduced birth weights, reduced viability, and behavioral alterations, among offspring of female rodents. Male rodents exposed to cadmium have been found to have testicular damage, reduction in sperm counts, Cadmium has produced mutagenic effects on mammalian cell cultures. Pre-existing pulmonary diseases (e.g., bronchitis, asthma) may be aggravated by inhalation exposure, particularly as fume. Chronic exposure by inhalation and/or ingestion may aggravate pre-existing diseases of the liver, kidneys, gastrointestinal system, musculoskeletal system, and nervous system. LD50: 2,330 mg/kg (oral/rat) LC50: 25mg/m3/30min (inhalation/rat) LD50: 3.5 mg/kg (intraperitoneal/mouse) LC50: No data available LD50: >5 gm/kg (oral/guinea pig) LC50: No data available LD50: No data available LC50: No data available In their intended manner of use, these products should not be released into the environment, and adverse effects on ecosystems are not anticipated under recommended conditions of use, storage, and disposal. Dispose of unused or unusable product in accordance with applicable Federal, State/Provincial, and local regulations. These products are not Hazardous Substances or Dangerous Goods per Acute Health Hazard; Chronic Health Hazard Ingredient(s) - U.S. Regulatory Information ------------------------------------------- SARA Title III - Section 313 Form "R"/TRI Reportable Chemical SARA Title III - Section 313 Form "R"/TRI Reportable Chemical SARA Title III - Section 313 Form "R"/TRI Reportable Chemical WHMIS Class(es) and Division(s): D1A, D2A Components on Ingredients DisclosureList: This MSDS Superceeds A Previous MSDS Dated: 07/20/2001 Although reasonable care has been taken in the preparation of this document, weextend no warranties and make no representations as to the accuracy or completeness of the information contained therein, and assume no responsibility regarding the suitability of this information for the user's intended purposes or for the consequences of its use. Each individual should make a determination as to the suitability of the information for their particular purpose(s). Lucas-Milhaupt, Inc. Handy & Harman Fairfield


Microsoft word - 090728_informationsbrief_nr3_uve_mk_v2

INFORMATIONSBRIEF Arbeitssicherheit, Forschung und Entwicklung, Gesundheitsschutz, Managementsysteme, Strategieberatung, Software uve • Informationsbrief Dritte Ausgabe Juli 2009 Gesundheitswissenschaftler vermuten jedoch durch Urlauber und ungünstige Witterungsbedin-die Schweinegrippe oder auch neue Influenza gungen einen starken Anstieg der Erkrankungsfäl-greift nun

Paroxetine in social phobia

The Efficacy of Paxil (Paroxetine) for Panic Disorder Journal : The Current Practice of Medicine Authors : Dr Sean D. Hood, Dr Spilios Argyropoulos, Prof David J. Nutt Corresponding Author : Sean Hood ([email protected]) Introduction Substantial advances into the pharmacological treatment of Panic Disorder (PD) have been made in the lasttwo decades. Although tricyclic antidepres

Copyright © 2010 Health Drug Pdf